Skip to main content
SpringerLink
Log in

Angiotensin-converting enzyme inhibitor in a human model of restenosis

  • Chapter
Angiotensin and the Heart

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) was introduces by Andreas Gruentzig in 1977, as an alternative treatment for coronary artery bypass grafting (CABG) to restore coronary blood flow in patients with obstructive coronary artery disease (15). Increased experience and advances in technology have resulted in a high primary success rate (over 90%) and a low compilation rate (death, non-fatal myocardial infarction; 4–5%) (9). However, the late restenosis rate (17% to 40%) still limits the long-term benefit of the procedure (21, 23, 47, 52).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, Gorlin R, Fuster V (1985) Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 5: 609–616

    Article  PubMed  CAS  Google Scholar 

  2. Barnathan ES, Schwartz JS, Taylor L, Laskey WK, Kleveland JP, Kussmaul WG, Hirshfeld JW (1987) Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 76: 125–134

    Article  PubMed  CAS  Google Scholar 

  3. Bilazarian SD, Currier JW, Haudenschild C, Hey man D, Powell J, Ryan TJ, Faxon DP (1991) Angiotensin converting enzyme inhibition reduces restenosis in experimental angioplasty [abstract]. J Am Coll Cardiol 17: 2: 268A

    Article  Google Scholar 

  4. Burnier M, Mooser V, Nussberger J, Waeber B, Brunner HR (1989) Correlation between plasma concentration of Cilazapril and hemodynamic and hormonal effects in healthy man. Br J Clin Pharmac 27: 189S–197S

    CAS  Google Scholar 

  5. Califf RM, Ohman EM, Frid DJ, Fortin DF, Mark DB, Hlatky MS, Herndon JE, Bengtson JR (1990) Restenosis: The clinical issues, in Topol EJ (ed): Textbook of Interventional Cardiology. Philadelphia, WB Saunders Co, 63: 394

    Google Scholar 

  6. Christen Y, Waeber B, Nussberger J, Porchet M, Borland RM, Lee RJ, Shum L, Tim- mermans PBMWH, Brunner HR (1991) Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation 83: 1333–1342

    Google Scholar 

  7. Churchill DA, Siegel CO, Dougherety KG, Raizner A, Minor ST (1991) Failure of enalapril to reduce coronary restenosis in a swine model (abstract). Circulation 84: 4: 11–297

    Google Scholar 

  8. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450–456

    PubMed  CAS  Google Scholar 

  9. Detre K, Holubkov R, Kelsey S, Cowley M, Kent K, Williams D, Myler R, Faxon D, Holmes D Jr, Bourassa M, Block P, Gosselin A, Bentivoglio L, Leatherman L, Dorros G, King S III, Galichia J, Al-Bassam M, Leon M, Robertson T, Passamani E, Co-Investigators of the NHLBI PTCA Registry (1988) Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981. The National Heart Lung Blood Institute Registry. N Engl J Med 318: 265–270

    Google Scholar 

  10. Dorros G, Cowley MJ, Simpson J, Bentifoglio LG, Block PC, Bourassa M, Detre K, Gosselin AJ, Gruentzig AR, Kelsey SF, Kent KM, Mock MB, Mullins SM, Myler RK, Passamani ER, Stertzer SH, Williams DO (1983) Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 67: 4: 723–730

    Article  PubMed  CAS  Google Scholar 

  11. Fingerle J, Au YPT, Clowes AW, Reidy MA (1990) Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Atheriosclerosis 10: 1082–1087

    CAS  Google Scholar 

  12. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA (1989) Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci 86: 8412–8416

    Article  PubMed  CAS  Google Scholar 

  13. Flemming RM, Kirkeeide RL, Smalling RW, Gould KL, Stuart Y (1991) Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary arteriography. J Am Coll Cardiol 18: 945–951

    Article  Google Scholar 

  14. Forrester JS, Fishbein M, Helfant R, Fagin J (1991) A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 17: 758–769

    Article  PubMed  CAS  Google Scholar 

  15. Gruentzig AR, Senning A, Siegenthaler WE (1979) Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med 301: 61-68

    Google Scholar 

  16. Hammacher A, Hellman U, Johnsson A, Östman A, Gunnarsson K, Westermark, B, Wasteson Ä, Heldin CH (1988) A major part of platelet-derived growth factor purified from human platelets is a heteromer of one A and one B chain. J Biol Chem 263: 16493 - 16498

    PubMed  CAS  Google Scholar 

  17. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA (1991) Effects of angiotensin-converting enzyme inhibition with Cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 18 (suppl H): 70–76

    Google Scholar 

  18. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW (1991) Prevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA): The search for a “magic bullet”. Am Heart J 122: 1: 171–187

    Article  PubMed  CAS  Google Scholar 

  19. Huber KC, Schwartz RS, Edwards WD, Camrud AR, Murphy JG, Jorgenson M, Holmes DR (1991) Restenosis and angiotensin-converting enzyme inhibition: effects on neointimal proliferation in a porcine coronary injury model (abstract). Circulation 84: 4: 11–298

    Google Scholar 

  20. Jawien A, Lindner V, Bowen-Pope DF, Schwartz SM, Reidy MA, Clowes AW (1990) Platelet derived growth factor ( PDGF) stimulates arterial smooth muscle cell proliferation in vivo (abstract ). FASEB 4: 342

    Google Scholar 

  21. Kaltenbach M, Kober G, Scherer D, Vallbracht C (1985) Recurrence rate after successful angioplasty. Eur Heart J 6: 276–281

    PubMed  CAS  Google Scholar 

  22. Lam JYT, Bourassa MG, Blaine L, Lachapelle C (1990) Can Cilazapril reduce the development of atherosclerotic changes in the balloon injured porcine carotid arteries? (abstract). Circulation 82: 4: 111–429

    Google Scholar 

  23. Leimgruber PP, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King III SB, Gruentzig AR (1986) Restenosis after successful angioplasty in patients with single-vessel disease. Circulation 73: 710–717

    Article  PubMed  CAS  Google Scholar 

  24. Lindner V, Reidy MA (1991) Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci 88: 3739–3743

    Article  PubMed  CAS  Google Scholar 

  25. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA (1991) Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68: 106–113

    PubMed  CAS  Google Scholar 

  26. Liu MW, Roubin GS, King SB (1989) Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374–1387

    Google Scholar 

  27. Mabin TA, Holmes DR Jr, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA (1985) Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 5: 198–202

    Google Scholar 

  28. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM (1990) PDGF ligand and receptor gene expression during repair ligand. J Cell Biol 111: 2149–2158

    Article  PubMed  CAS  Google Scholar 

  29. Naftilan AJ, Pratt RE, Dzau VJ (1989) Induction of platelet derived growth factor A chain and C-myc gene expressions by angiotensin II in culture rat vascular smooth muscle cells. J Clin Invest 83: 1419–1424

    Article  PubMed  CAS  Google Scholar 

  30. Nussberger J, Brunner DB, Waeber B, Brunner HR (1985) True versus immunoreactive angiotensin II in human plasma. Hypertension 7 (suppl I):l–17

    Google Scholar 

  31. Owens GK, Schwartz SM (1983) Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Cir Res 53: 491–500

    CAS  Google Scholar 

  32. Owens GK, Reidy MA (1985) Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Cir Res 57: 659–670

    Google Scholar 

  33. Owens GK (1987) Influences of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 9: 178–187

    PubMed  CAS  Google Scholar 

  34. Powell JS, Clozel JP, Müller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186–188

    Article  PubMed  CAS  Google Scholar 

  35. Powell JS, Muller RKM, Rouge M, Kuhn H, Hefti F, Baumgartner HR (1990) The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacology 16 (suppl 4): S42–S49

    Article  CAS  Google Scholar 

  36. Powell JS, Rouge M, Muller RK, Baumgartner HR (1991) Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction and vascular smooth muscle cells. Basic Research in Cardiology 86 (suppl I): 65–74

    PubMed  CAS  Google Scholar 

  37. Rakugi H, Krieger J, Wang DS, Dzau VJ, Pratt RE (1991) Induction of angiotensin converting enzyme in neointima after balloon injury (abstract). Circulation 84: 4: 11–113

    Google Scholar 

  38. Reiber JHC, Serruys PW, Kooyman CJ, Wijns W, Slager CJ, Gerbrands M, Schuurbiers JCH, den Boer A, Hugenholtz PG (1985) Assessment of short, medium and long term variations in arterial dimensions from computer assisted quantification of coronary cineangiograms. Circulation 71: 280–288

    Article  PubMed  CAS  Google Scholar 

  39. Reiber JHC, Serruys PW (1990) Quantitative coronary angiography, in Marcus ML, Schelbert HR, Skorton DJ, Wolf GL (ed): Cardiac Imaging: A Companion to Braunwald’s Heart Disease. Philadelphia, WB Saunders Co, pp 211–280

    Google Scholar 

  40. Rensing BJ, Hermans WRM, Deckers JW, de Feyter PJ, Tijssen JGP, Serruys PW (1992) Luminal narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution. A quantitative angiographic study in 1445 successfully dilated lesions. J Am Coll Cardiol 9: 939–945

    Google Scholar 

  41. Ross R (1986) The pathogenesis of atherosclerosis. An update. N Engl J Med 314: 488–500

    Article  PubMed  CAS  Google Scholar 

  42. Sahni R, Maniet AR, Voci G, Banka VS (1991) Prevention of restenosis by lovastatin after successful angioplasty. Am Heart J 121: 1600–1608

    Article  PubMed  CAS  Google Scholar 

  43. Schwartz SM, Campbell GR, Campbell JH (1986) Replication of smooth muscle cells in vascular disease. Circ Res 58: 427–444

    PubMed  CAS  Google Scholar 

  44. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR (1988) Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318: 1714–1719

    Article  PubMed  CAS  Google Scholar 

  45. Schwartz RS, Huber KC, Edwards WD, Camrud AR, Jorgenson M, Holmes DR (1991) Coronary restenosis and the importance of mural thrombus: results in a porcine coronary model (abstract). Circulation 84: 4: 11–71

    Google Scholar 

  46. Scott-Burden T, Resink TJ, Hahn AWA, Bühler FR (1990) Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II. J Cardiovasc Pharm 16 (suppl 7): 17–20

    Google Scholar 

  47. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, Ten Katen HJ, van Es GA, Hugenholtz PG (1988) Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 77: 361–371

    CAS  Google Scholar 

  48. Serruys PW, Rensing BJ, Luijten HE, Hermans WRM, Beatt KJ (1990) Restenosis following coronary angioplasty. In Meier B (ed) Interventional Cardiology. Bern: Hogrefe and Huber Publishers, 79: 115

    Google Scholar 

  49. Serruys PW, Rutsch W, Heyndrickx GR, Danchin N, Mast G, Wijns W, Rensing BJ, Vos J, Stibbe J (1991) for the CARPORT study group. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2 receptor blockade. A randomized, double blind, placebo controlled trial. Circulation 84: 1568–1580

    Google Scholar 

  50. Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr, Dewanjee MK, Badimon L, Fuster V (1985) Balloon angioplasty: Natural history of the pathophysiological response to injury in the pig model. Cir Res 57: 105–112

    Google Scholar 

  51. The Multicenter European Research Trial with Cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (Mercator) study Group (1992) Circulation 86: 100–110

    Google Scholar 

  52. Vandormael MG, Deligonul U, Kern M, Harper M, Presant S, Gibson P, Galan K, Chaitman BR (1987) Multilesion coronary angioplasty: clinical and angiographic follow- up. J Am Coll Cardiol 10: 246–252

    Article  PubMed  CAS  Google Scholar 

  53. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP (1987) Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 75: 636–642

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Center, Onze Lieve Vrouw Ziekenhuis, Moorselbaan 164, B-9300, Aalst, Belgium

    G. R. Heyndrickx (MD, PhD, FACC)

Authors
  1. G. R. Heyndrickx
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, der Universitä Regensburg, Universitätsstraße 31, 8400, Regensburg, Germany

    H. Grobecker

  2. Abt. Pathophysiologie Zentrum Innere Medizin, Universitätsklinikum Essen, Hufelandstraße 55, 4300, Essen, Germany

    Gerd Heusch

  3. Abt. für Kardiologie, Pneumologie, Med. Klinik und Poliklinik B der Heinrich-Heine-Universität, Moorenstraße 5, 4000, Düsseldorf 1, Germany

    B. E. Strauer

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Heyndrickx, G.R. (1993). Angiotensin-converting enzyme inhibitor in a human model of restenosis. In: Grobecker, H., Heusch, G., Strauer, B.E. (eds) Angiotensin and the Heart. Steinkopff. https://doi.org/10.1007/978-3-642-72497-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72497-8_12

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0936-8

  • Online ISBN: 978-3-642-72497-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation